Belarusian Ministry of health registered a new drug Bisoprolol, capsule 2.5 mg, capsule 5 mg and capsule 10 mg.Bisoprolol-M(IC is a selective β-adrenoceptor antagonist lack of its symptomatic activity.
Action: hypotensive, antiarrhythmic, and antianginal.
Indications: hypertension, ischemic disease, prevention of stenocardia attacks, chronic heart failure of moderate stable type without aggravations for the last 6 weeks.
The drug Bisoprolol-MIC in capsule dosage form has advantages against tablets, i.e. less technological stages in capsule manufacturing if compared with tablet one, in particular granulation, granulate drying, compressing is not needed, hence less probable is the presence of process and related substances in the drug.
Bisoprolol-MIC, capsules, is successfully administered in in-patient and outpatient departments; it is effective in complex therapy of hypertension, ischemic disease, and chronic heart failure.
Since December 2014 Minskintercaps U.V. has launched marketing the drug Bisoprolol-MIC capsule 2.5 mg, capsule 5 mg and capsule 10 mg.